Acute coronary syndromes

consider a dose-adjusted insulin infusion with regular monitoring of blood glucose levels. [2011] 1.3.2 Do not routinely offer intensive insulin therapy (an intravenous infusion of insulin and glucose with or without potassium) to manage hyperglycaemia (blood glucose above 11.0 mmol/litre) in people admitted to hospital for an acute coronary syndrome unless clinically indicated. [2011] Identifying people with hyperglycaemia after acute coronary syndrome who are at high risk of developing diabetes 1.3.3 Offer all people with hyperglycaemia after acute coronary syndrome and without known diabetes tests for: • HbA1c levels before discharge • fasting blood glucose levels no earlier than 4 days after the onset of acute coronary syndrome. Acute coronary syndromes (NG185) These tests should not delay discharge. [2011] 1.3.4 Do not routinely offer oral glucose tolerance tests to people with hyperglycaemia after acute coronary syndrome and without known diabetes if HbA1c and fasting blood glucose levels are within the normal range. [2011] Advice and ongoing monitoring for people with hyperglycaemia after acute coronary syndrome and without known diabetes 1.3.5 Offer people with hyperglycaemia after acute coronary syndrome and without known diabetes lifestyle advice on the following: • healthy eating • physical exercise • weight management • smoking cessation •
